In one microarray containing 31 TNBC specimens, as well as 15 hormone-receptor- or HER-2-positive breast cancers, positive staining occurred in over 95% of the tumors, with 3+ staining in 65% of the cases. This evidence concerns the gene NR4A1 and breast carcinoma.